Vitamin Shoppe, Inc. (VSI) At $4.05 Forms Bottom; Startek (SRT) Has 1.41 Sentiment

StarTek, Inc. provides business process outsourcing services in the United States, Canada, Honduras, Jamaica, and the Philippines. The company has market cap of $176.76 million. It operates in three divisions: Domestic, Nearshore, and Offshore. It has a 82.33 P/E ratio. The companyÂ’s service offerings include customer care, sales support, inbound sales, complex order processing, accounts receivable management, technical and product support, up-sell and cross-sell opportunities, customer intelligence analytics, and other industry-specific processes.

Vitamin Shoppe, Inc. (VSI) formed multiple bottom with $3.69 target or 9.00% below today’s $4.05 share price. Vitamin Shoppe, Inc. (VSI) has $97.09M valuation. The stock increased 3.85% or $0.15 during the last trading session, reaching $4.05. About 137,197 shares traded. Vitamin Shoppe, Inc. (NYSE:VSI) has declined 57.70% since February 13, 2017 and is downtrending. It has underperformed by 74.40% the S&P500.

Analysts await Vitamin Shoppe, Inc. (NYSE:VSI) to report earnings on March, 7. They expect $-0.24 EPS, down 166.67% or $0.60 from last year’s $0.36 per share. After $-0.03 actual EPS reported by Vitamin Shoppe, Inc. for the previous quarter, Wall Street now forecasts 700.00% negative EPS growth.

Among 11 analysts covering Vitamin Shoppe (NYSE:VSI), 1 have Buy rating, 2 Sell and 8 Hold. Therefore 9% are positive. Vitamin Shoppe has $41 highest and $3 lowest target. $19.67’s average target is 385.68% above currents $4.05 stock price. Vitamin Shoppe had 26 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital initiated the shares of VSI in report on Friday, September 23 with “Equal Weight” rating. As per Thursday, November 5, the company rating was maintained by Deutsche Bank. The firm has “Neutral” rating given on Tuesday, November 17 by Robert W. Baird. The company was maintained on Thursday, August 10 by Deutsche Bank. The firm has “Hold” rating given on Friday, September 15 by Robert W. Baird. Morgan Stanley maintained Vitamin Shoppe, Inc. (NYSE:VSI) on Monday, October 2 with “Equal-Weight” rating. The firm earned “Neutral” rating on Thursday, October 27 by JP Morgan. As per Thursday, January 19, the company rating was downgraded by Goldman Sachs. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, August 10. The firm has “Underweight” rating by Morgan Stanley given on Tuesday, January 17.

The stock decreased 0.09% or $0.01 during the last trading session, reaching $10.95. About 5,795 shares traded. StarTek, Inc. (SRT) has risen 150.65% since February 13, 2017 and is uptrending. It has outperformed by 133.95% the S&P500.

Heartland Advisors Inc holds 0.83% of its portfolio in StarTek, Inc. for 1.09 million shares. Eam Investors Llc owns 183,761 shares or 0.29% of their US portfolio. Moreover, Ancora Advisors Llc has 0.13% invested in the company for 185,364 shares. The California-based Rbf Capital Llc has invested 0.07% in the stock. Bridgeway Capital Management Inc, a Texas-based fund reported 156,000 shares.